1214 related articles for article (PubMed ID: 23144150)
1. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
2. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
[TBL] [Abstract][Full Text] [Related]
3. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.
Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI
Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121
[TBL] [Abstract][Full Text] [Related]
4. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis.
Chen X; Xu F; Wang Y; Pan Y; Lu D; Wang P; Ying K; Chen E; Zhang W
Cancer; 2007 Aug; 110(4):835-44. PubMed ID: 17599760
[TBL] [Abstract][Full Text] [Related]
5. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
[TBL] [Abstract][Full Text] [Related]
6. Breath analysis in non small cell lung cancer patients after surgical tumour resection.
Poli D; Goldoni M; Caglieri A; Ceresa G; Acampa O; Carbognani P; Rusca M; Corradi M
Acta Biomed; 2008; 79 Suppl 1():64-72. PubMed ID: 18924311
[TBL] [Abstract][Full Text] [Related]
7. Optimization of volatile markers of lung cancer to exclude interferences of non-malignant disease.
Zou Y; Zhang X; Chen X; Hu Y; Ying K; Wang P
Cancer Biomark; 2014; 14(5):371-9. PubMed ID: 25171479
[TBL] [Abstract][Full Text] [Related]
8. Determination of volatile organic compounds as biomarkers of lung cancer by SPME-GC-TOF/MS and chemometrics.
Rudnicka J; Kowalkowski T; Ligor T; Buszewski B
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3360-6. PubMed ID: 21982505
[TBL] [Abstract][Full Text] [Related]
9. Exhaled biomarkers in lung cancer.
Horváth I; Lázár Z; Gyulai N; Kollai M; Losonczy G
Eur Respir J; 2009 Jul; 34(1):261-75. PubMed ID: 19567608
[TBL] [Abstract][Full Text] [Related]
10. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ
Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643
[TBL] [Abstract][Full Text] [Related]
11. Breath carbonyl compounds as biomarkers of lung cancer.
Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA
Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567
[TBL] [Abstract][Full Text] [Related]
12. Organic metabolites in exhaled human breath--a multivariate approach for identification of biomarkers in lung disorders.
Gaspar EM; Lucena AF; Duro da Costa J; Chaves das Neves H
J Chromatogr A; 2009 Apr; 1216(14):2749-56. PubMed ID: 19036381
[TBL] [Abstract][Full Text] [Related]
13. Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma.
Kumar S; Huang J; Abbassi-Ghadi N; Mackenzie HA; Veselkov KA; Hoare JM; Lovat LB; Španěl P; Smith D; Hanna GB
Ann Surg; 2015 Dec; 262(6):981-90. PubMed ID: 25575255
[TBL] [Abstract][Full Text] [Related]
14. The application of statistical methods using VOCs to identify patients with lung cancer.
Ulanowska A; Kowalkowski T; Trawińska E; Buszewski B
J Breath Res; 2011 Dec; 5(4):046008. PubMed ID: 22071773
[TBL] [Abstract][Full Text] [Related]
15. Breath testing as a method for detecting lung cancer.
Taivans I; Bukovskis M; Strazda G; Jurka N
Expert Rev Anticancer Ther; 2014 Feb; 14(2):121-3. PubMed ID: 24467216
[TBL] [Abstract][Full Text] [Related]
16. Breath biomarkers of liver cirrhosis.
Dadamio J; Van den Velde S; Laleman W; Van Hee P; Coucke W; Nevens F; Quirynen M
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Sep; 905():17-22. PubMed ID: 22921634
[TBL] [Abstract][Full Text] [Related]
17. Selected ion flow tube mass spectrometry analysis of exhaled breath for volatile organic compound profiling of esophago-gastric cancer.
Kumar S; Huang J; Abbassi-Ghadi N; Španěl P; Smith D; Hanna GB
Anal Chem; 2013 Jun; 85(12):6121-8. PubMed ID: 23659180
[TBL] [Abstract][Full Text] [Related]
18. Investigation of lung cancer biomarkers by hyphenated separation techniques and chemometrics.
Buszewski B; Ulanowska A; Kowalkowski T; Cieśliński K
Clin Chem Lab Med; 2011 Oct; 50(3):573-81. PubMed ID: 22035139
[TBL] [Abstract][Full Text] [Related]
19. Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro.
Sponring A; Filipiak W; Mikoviny T; Ager C; Schubert J; Miekisch W; Amann A; Troppmair J
Anticancer Res; 2009 Jan; 29(1):419-26. PubMed ID: 19331181
[TBL] [Abstract][Full Text] [Related]
20. Effects of Curative Colorectal Cancer Surgery on Exhaled Volatile Organic Compounds and Potential Implications in Clinical Follow-up.
Altomare DF; Di Lena M; Porcelli F; Travaglio E; Longobardi F; Tutino M; Depalma N; Tedesco G; Sardaro A; Memeo R; de Gennaro G
Ann Surg; 2015 Nov; 262(5):862-6; discussion 866-7. PubMed ID: 26583677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
